NRX Pharmaceuticals, Inc.

( )
NRXP After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. 0.55%44.190.9%$1265.49m
ABBVAbbVie, Inc. 0.85%107.311.9%$1024.22m
JNJJohnson & Johnson 0.54%164.820.7%$998.60m
MRKMerck & Co., Inc. 1.40%73.050.7%$880.20m
LLYEli Lilly & Co. 1.65%232.061.1%$598.53m
BMYBristol-Myers Squibb Co. 0.78%60.621.0%$573.53m
AZNAstraZeneca Plc 1.26%59.481.0%$335.33m
NVSNovartis AG 0.93%83.570.2%$162.07m
CRVSCorvus Pharmaceuticals, Inc. -6.14%7.030.7%$143.77m
GSKGlaxoSmithKline Plc 0.15%39.340.2%$135.46m
SNYSanofi 0.50%48.720.2%$123.92m
RGENRepligen Corp. 3.55%324.216.8%$120.88m
RPRXRoyalty Pharma Plc 2.32%37.130.1%$120.28m
VTRSViatris, Inc. 0.68%13.340.0%$108.50m
NVONovo Nordisk A/S 1.24%102.120.1%$102.45m

Company Profile

NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded on September 18, 2017 and is headquartered in Wilmington, DE.